在大流行期间建立医院间ecmo运输规划:吸取的主要经验教训。

IF 1.4 4区 医学 Q4 ENGINEERING, BIOMEDICAL
Mustafa Mert Ozgur, Ece Altınay, Halide Ogus, Hakan Hançer, Hakan Yusuf Koksal, Uzeyir Yılmaz, Tanıl Ozer, Mehmet Aksut, Ozge Altas, İsmail Yerli, Mine Simsek, Atakan Erkilic, Sabit Sarıkaya, Kaan Kırali
{"title":"在大流行期间建立医院间ecmo运输规划:吸取的主要经验教训。","authors":"Mustafa Mert Ozgur, Ece Altınay, Halide Ogus, Hakan Hançer, Hakan Yusuf Koksal, Uzeyir Yılmaz, Tanıl Ozer, Mehmet Aksut, Ozge Altas, İsmail Yerli, Mine Simsek, Atakan Erkilic, Sabit Sarıkaya, Kaan Kırali","doi":"10.1177/03913988241300860","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The emergence of COVID-19 has amplified the importance of efficient patient transfer, leading to the idea of inter-hospital ECMO transport programs. However, there are limited studies on ECMO transfer protocols and experiences during COVID pandemic. This study aimed to evaluate the effectiveness our transport program and provide insights into establishing and maintaining ECMO programs.</p><p><strong>Methods: </strong>Over the period from April 2020 to December 2021, 76 patients with severe hypoxic COVID-19 ARDS were transferred to our center under a veno-venous ECMO support. The transfers were performed by the experienced transport ECMO-team, covering both intracity and intercity transports from various hospitals in Istanbul and the Marmara Region.</p><p><strong>Results: </strong>Mean age was 44 (34-54) years. Time until ECMO initiation was 6 (3-11.2) days. The average transport distance was 36.6 ± 58.7 km. Average intracity and intercity transport distance were 17.5 ± 15.7 and 121 ± 96.6 km, respectively. ECMO wean rate was 40.7% and survival to discharge (home) was 38.1%. No major adverse events occurred during the transfer process. In one transport, the oxygen tank was instantly replenished on the road due to the decrease in the oxygen level in the tank.</p><p><strong>Conclusion: </strong>In conclusion, this study contributed to the knowledge surrounding ECMO transport programs during pandemics, emphasized the importance of expert coordination and careful patient management with demonstrating feasibility of mobile ECMO program .</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"40-47"},"PeriodicalIF":1.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Establishing an interhospital ECMO-transport program during a pandemic: Key lessons learned.\",\"authors\":\"Mustafa Mert Ozgur, Ece Altınay, Halide Ogus, Hakan Hançer, Hakan Yusuf Koksal, Uzeyir Yılmaz, Tanıl Ozer, Mehmet Aksut, Ozge Altas, İsmail Yerli, Mine Simsek, Atakan Erkilic, Sabit Sarıkaya, Kaan Kırali\",\"doi\":\"10.1177/03913988241300860\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The emergence of COVID-19 has amplified the importance of efficient patient transfer, leading to the idea of inter-hospital ECMO transport programs. However, there are limited studies on ECMO transfer protocols and experiences during COVID pandemic. This study aimed to evaluate the effectiveness our transport program and provide insights into establishing and maintaining ECMO programs.</p><p><strong>Methods: </strong>Over the period from April 2020 to December 2021, 76 patients with severe hypoxic COVID-19 ARDS were transferred to our center under a veno-venous ECMO support. The transfers were performed by the experienced transport ECMO-team, covering both intracity and intercity transports from various hospitals in Istanbul and the Marmara Region.</p><p><strong>Results: </strong>Mean age was 44 (34-54) years. Time until ECMO initiation was 6 (3-11.2) days. The average transport distance was 36.6 ± 58.7 km. Average intracity and intercity transport distance were 17.5 ± 15.7 and 121 ± 96.6 km, respectively. ECMO wean rate was 40.7% and survival to discharge (home) was 38.1%. No major adverse events occurred during the transfer process. In one transport, the oxygen tank was instantly replenished on the road due to the decrease in the oxygen level in the tank.</p><p><strong>Conclusion: </strong>In conclusion, this study contributed to the knowledge surrounding ECMO transport programs during pandemics, emphasized the importance of expert coordination and careful patient management with demonstrating feasibility of mobile ECMO program .</p>\",\"PeriodicalId\":13932,\"journal\":{\"name\":\"International Journal of Artificial Organs\",\"volume\":\" \",\"pages\":\"40-47\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Artificial Organs\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1177/03913988241300860\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/1 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Artificial Organs","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/03913988241300860","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:COVID-19的出现放大了高效患者转移的重要性,导致了医院间ECMO转移计划的想法。然而,关于COVID大流行期间ECMO转移方案和经验的研究有限。本研究旨在评估我们的运输计划的有效性,并为建立和维持ECMO计划提供见解。方法:2020年4月至2021年12月,76例重症低氧COVID-19 ARDS患者在静脉-静脉ECMO支持下转入我中心。转运工作由经验丰富的ecmo运输小组进行,包括从伊斯坦布尔和马尔马拉地区各医院进行的城际和城际运输。结果:平均年龄44岁(34 ~ 54岁)。至ECMO启动时间为6(3-11.2)天。平均输运距离为36.6±58.7 km。城市内和城际平均交通距离分别为17.5±15.7 km和121±96.6 km。ECMO断奶率为40.7%,出院存活率为38.1%。转移过程中未发生重大不良事件。在一次运输中,由于氧气罐中的氧气含量下降,氧气罐在路上立即补充。结论:本研究总结了流行病期间ECMO转运方案的相关知识,强调了专家协调和谨慎的患者管理的重要性,并论证了移动ECMO方案的可行性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Establishing an interhospital ECMO-transport program during a pandemic: Key lessons learned.

Background: The emergence of COVID-19 has amplified the importance of efficient patient transfer, leading to the idea of inter-hospital ECMO transport programs. However, there are limited studies on ECMO transfer protocols and experiences during COVID pandemic. This study aimed to evaluate the effectiveness our transport program and provide insights into establishing and maintaining ECMO programs.

Methods: Over the period from April 2020 to December 2021, 76 patients with severe hypoxic COVID-19 ARDS were transferred to our center under a veno-venous ECMO support. The transfers were performed by the experienced transport ECMO-team, covering both intracity and intercity transports from various hospitals in Istanbul and the Marmara Region.

Results: Mean age was 44 (34-54) years. Time until ECMO initiation was 6 (3-11.2) days. The average transport distance was 36.6 ± 58.7 km. Average intracity and intercity transport distance were 17.5 ± 15.7 and 121 ± 96.6 km, respectively. ECMO wean rate was 40.7% and survival to discharge (home) was 38.1%. No major adverse events occurred during the transfer process. In one transport, the oxygen tank was instantly replenished on the road due to the decrease in the oxygen level in the tank.

Conclusion: In conclusion, this study contributed to the knowledge surrounding ECMO transport programs during pandemics, emphasized the importance of expert coordination and careful patient management with demonstrating feasibility of mobile ECMO program .

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Artificial Organs
International Journal of Artificial Organs 医学-工程:生物医学
CiteScore
3.40
自引率
5.90%
发文量
92
审稿时长
3 months
期刊介绍: The International Journal of Artificial Organs (IJAO) publishes peer-reviewed research and clinical, experimental and theoretical, contributions to the field of artificial, bioartificial and tissue-engineered organs. The mission of the IJAO is to foster the development and optimization of artificial, bioartificial and tissue-engineered organs, for implantation or use in procedures, to treat functional deficits of all human tissues and organs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信